Intranasal Vasopressin Treatment in Children With Autism
Latest Information Update: 25 Mar 2024
At a glance
- Drugs Vasopressin (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- 19 Mar 2024 Status changed from active, no longer recruiting to completed.
- 20 Jan 2024 Status changed from recruiting to active, no longer recruiting.
- 11 Feb 2021 Protocol amended to change study phase from II to II/III and masking changed from open to double blinding.